Breaking News Headlines Today

News from nutraingredients-asia.com

See all of Nutraingredients-asia.com’s headline news. Compare how the top news stories are covered by left-wing and right-wing news sources.

We’ve discovered 106 headlines written by Nutraingredients-asia.com during the past 3 months.

We’ve assigned a media bias rating of unknown to Nutraingredients-asia.com. You can read more about our methodology here.

Nutraingredients-asia.com’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Nutraingredients-asia.com

Where is Nutraingredients-asia.com located?Nutraingredients-asia.com's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Cell Biotech to enter Thailand and Philippines on the back of strong export growth

South Korea's Cell Biotech looks to enter Thailand and Philippines within 2025, on the back of continued performance as top K-probiotic exporter.Thailand · Thailand Read Article

Tocotrienols and cellular health: PhytoGaia embarks on second clinical trial

PhytoGaia is embarking on its second human clinical trial assessing the potential effects of tocotrienols and plant squalene for cellular health and telomere preservation.Health · Singapore Read Article

Nearly 240 adverse event reports on B6 received in first half of 2025

Australia’s Therapeutic Goods Administration (TGA) received 239 adverse event reports for complementary medicines containing vitamin B6 between January 1 and June 30 this year.Medical · Australia Read Article

Bubs Australia Appoints Joe Coote as New CEO

Bubs Australia Limited (ASX:BUB) has announced the appointment of Mr. Joe Coote as its new Chief Executive Officer, effective immediately. Bubs Australia is a company focused on providing premium infant nutrition products, particularly goat milk-based formula and other clean-label options. The company aims to cater to families seeking high-quality alternatives in the infant nutrition market. Mr. Coote brings over 20 years of leadership experienc…Business · Australia See the Story

News from nutraingredients-asia.com

News from nutraingredients-asia.com

Information about Nutraingredients-asia.com

Media Bias Ratings

Factuality

Ownership

Top Nutraingredients-asia.com News

China sees growing interest from Italian nutra firms

Samyang aims to ‘strengthen dominance’ in zero-sugar hangover relief market

Kirin finds link between frailty and low pDC activity

MFDS considers hydrolyzed milk protein as sleep support ingredient

Haleon eyes growth opportunities in lower income markets

B. breve shown to improve metabolic, gut health

South Korea Bans Imports of Supplements Containing 7-OH

Cell Biotech to enter Thailand and Philippines on the back of strong export growth

Tocotrienols and cellular health: PhytoGaia embarks on second clinical trial

Nearly 240 adverse event reports on B6 received in first half of 2025

Bubs Australia Appoints Joe Coote as New CEO

Similar News Topics

Topics Most Covered by nutraingredients-asia.com

Sources Covering Similar Topics

Breaking News Topics Related to Nutraingredients-asia.com

Information about Nutraingredients-asia.com

Media Bias Ratings

Factuality

Ownership

MFDS considers hydrolyzed milk protein as sleep support ingredient

Haleon eyes growth opportunities in lower income markets

B. breve shown to improve metabolic, gut health

South Korea Bans Imports of Supplements Containing 7-OH

Cell Biotech to enter Thailand and Philippines on the back of strong export growth

Tocotrienols and cellular health: PhytoGaia embarks on second clinical trial

Nearly 240 adverse event reports on B6 received in first half of 2025

Bubs Australia Appoints Joe Coote as New CEO